Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. - Wikidata - wikimedia - TriplyDB

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

http://www.wikidata.org/entity/Q34717889

about

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials HIV and tuberculosis--science and implementation to turn the tide and reduce deaths Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.HIV-associated lung infections and complications in the era of combination antiretroviral therapy.Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy.Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil.Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007 Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.HIV-Associated Tuberculosis.Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.Antiretroviral therapy for tuberculosis control in nine African countries.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection PEPFAR support for the scaling up of collaborative TB/HIV activities Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection Diagnostic performance of interferon-gamma releasing assay in HIV-infected patients in China.Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.

P2860

Q26778385-D5111BBF-44DC-4387-AE03-23441144929D Q26824501-5D926A1D-C3F6-473B-982F-14547B208415 Q27012753-DFB9BD01-F7A3-4A78-9921-09286B81C6DB Q27309915-A167CF67-D263-435A-88F3-FA3FA2AB2565 Q27693307-E97CEC20-1973-492C-8CC1-02397714119F Q28359604-45EE981E-E2BC-49D2-A5E5-93324A9C5163 Q28483035-ADBE24DD-9722-4F8A-BA6C-7CF89A9D60F5 Q28487920-46D55BCE-7BB9-426E-808D-17CF6DF6BCAB Q30385976-8C86AF56-CEF6-4BBE-B631-27C3198F6772 Q33616426-A5896B60-2B35-42EC-9DB0-18681BBA3BF8 Q33717183-ED1462B7-35D2-452B-85B9-29CA0C80C88E Q33909179-3978F76C-7145-4BE1-938D-8603B0196641 Q33920318-62B660A5-8F06-41E6-B46B-CC14F12376B5 Q34005907-382C42EC-3F52-46A7-83AD-96E93BA1939B Q34020551-8292AF55-2D48-45BA-BA71-B04780774510 Q34143510-53C58369-ABE1-47CE-8402-C5660EF69823 Q34146085-8F2AF1EE-51A9-4ACA-92DB-8D85ABBCAA65 Q34222186-D4C10C19-8FCF-4CB7-8251-399C0503A708 Q34320245-8519197F-64D5-45E0-86E1-D043CDBBC555 Q34387168-8F33959A-6BB4-481D-8095-C3F34D1CC9C5 Q34515554-A11CEEFF-87DD-4C2F-AADE-88C5928C079D Q34519039-26E69B3A-8519-4835-97BD-75232C5BBAEF Q34532773-7479B12B-ED21-48B3-B882-103ABA056DF8 Q34575195-6AF12C94-3D03-4B5E-A7BD-CD482ACC1AC2 Q34649281-05334AAC-1E75-43F7-AD48-20C95B3165E5 Q34785461-9A425AAC-68DF-40AA-BD3A-61270972697A Q34914625-25C0A884-794A-4E46-A998-3E7802694324 Q34926355-5652BA8C-6ED5-4B03-A487-A5AEB2CAF898 Q34981656-310F8DA1-2F05-4B34-AB68-24254937B040 Q34999621-5476FE06-E754-44FC-901C-2747A815E897 Q35089059-E9232E3D-A032-46F2-8E7A-AC3BA24C104A Q35094201-DEECDD78-0C46-407C-8057-0DDAC2029A0C Q35095036-A42CC6CA-41A2-4996-AA34-C815729FAECD Q35173497-21AFF5A6-973D-414C-832F-7E731A03FCD8 Q35195833-69CB3A50-62E1-42C3-8ED2-BA41523E4AD5 Q35297467-CCD4B8B2-FE27-4C68-8AB0-4E47AF7E1642 Q35336540-CC43EEF8-F798-4FB1-A2B6-57A51274EA60 Q35382545-C91337D7-F986-4CC3-8976-15233DBC651A Q35567798-279191F3-2D3D-4EC2-A173-56EB2615775E Q35656939-A04CA1B5-F9FA-4634-8FA0-46DA242FF355

P2860

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

http://www.wikidata.org/entity/Q34717889

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@ast

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@en

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@nl

type

label

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@ast

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@en

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@nl

prefLabel

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@ast

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@en

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@nl

P1433

Q34717889-9E7F8A1B-D1A4-429C-BA67-758BBEF06599

P1476

Q34717889-B217CCAE-3039-4B5F-B222-E6656FD9F2E8

P2093

Q34717889-0C05DBB5-8FEF-49A0-AA9A-AD307C199FD2

Q34717889-325B3B53-1FCC-48CB-8EAB-0E9C9A5EE3B9

Q34717889-5ED50397-A511-4C90-831D-6523E1AD2B0F

Q34717889-96AC9650-8D96-4BCE-BCAD-1FDCE6713DBC

Q34717889-9FA1B0C0-4C93-47C7-B695-610B11083A27

Q34717889-B2EAEBF1-B042-4BBE-B878-C16D97AA7C1B

Q34717889-B6B9B659-0B6A-4F34-80BB-1B7E82747035

Q34717889-E7E541BB-7DD0-4694-838B-7FB2D69C0DCA

Q34717889-E92A3CC9-AB84-417F-B804-AD4DFB4D6878

P2860

Q34717889-0D94388C-70CF-4190-A11A-1A09E0A5E974

Q34717889-1683644E-C432-483F-A3A1-932AB68AF0DC

Q34717889-1907E987-A580-44A0-9A39-5A55E2D89E60

Q34717889-1EB47269-C42D-4553-B9DA-28EA58ACE8C4

Q34717889-200E7116-B9B6-44D0-890D-12BCC36DA580

Q34717889-22778B2B-2694-4351-AE05-B4891E68EE33

Q34717889-2516104F-CBE9-4DB8-B696-C56247A61279

Q34717889-33591DD0-9BF5-4047-BAE8-DE677CCE1949

Q34717889-43875E26-10E6-4FF0-9EB6-D05A6D907D69

Q34717889-55320926-3A2A-40D5-9EF0-F024E28483B0

P304

Q34717889-D018D69B-8749-489B-AAC8-5171CB71A5C2

P31

Q34717889-293EC96A-CE2D-408F-84A8-37FA1AC68076

P356

Q34717889-FA4407E3-6653-4836-97AB-4C348E64084A

P407

Q34717889-EE34040B-F237-455F-B3B4-AAFBE8EDE187

P433

Q34717889-0977D48A-EFE3-4CEB-ABD6-BD9FF0EB370E

P478

Q34717889-88B221D8-C25F-4C3A-BDD5-C9D5A544C29E

P50

Q34717889-360C8EF3-A78F-43B3-9509-64BA8143E4DD

P577

Q34717889-538E4536-6AFD-41D1-9DAD-1F9D7068DBDC

P698

Q34717889-841F59AE-9BFC-405C-854A-AE9E231993CC

P921

Q34717889-0B1991DE-FFEF-4DC5-B846-0D3EFA381653

Q34717889-6C39CD09-2D9D-4895-BA88-A4F9A7D72250

P932

Q34717889-2AE77A04-26E0-4AD5-9E26-83241DAB5A3E

P356

QAD.0B013E328327964F

P1433

P1476

Isoniazid preventive therapy, ...... Africa: a prospective cohort.

@en

P2093

Glenda E Gray

http://www.w3.org/2001/XMLSchema#string

Helen Struthers

http://www.w3.org/2001/XMLSchema#string

James A McIntyre

http://www.w3.org/2001/XMLSchema#string

Jonathan E Golub

http://www.w3.org/2001/XMLSchema#string

Lerato Mohapi

http://www.w3.org/2001/XMLSchema#string

Mosa Moshabela

http://www.w3.org/2001/XMLSchema#string

Neil A Martinson

http://www.w3.org/2001/XMLSchema#string

Nkeko Thsabangu

http://www.w3.org/2001/XMLSchema#string

Paul Pronyk

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of latent tuberculosis infection in HIV infected persons

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Isoniazid preventive therapy and risk for resistant tuberculosis.

Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

Controlled chemoprophylaxis trials in tuberculosis. A general review.

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

P304

631-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E328327964F

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Richard E Chaisson

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19525621

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

Aafrikaa Kibbaa

P932

3063949

http://www.w3.org/2001/XMLSchema#string